1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Cardiopulmonary Oxygenator Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Cardiopulmonary Oxygenator Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Cardiopulmonary Oxygenator Market Regional Analysis
6.2 North America Cardiopulmonary Oxygenator Market Revenue 2020-2028 (US$ Million)
6.3 North America Cardiopulmonary Oxygenator Market Forecast Analysis
7. North America Cardiopulmonary Oxygenator Market Analysis – by Product
7.1 Bubble Oxygenator and Membrane Oxygenator
- 7.1.1 Overview
- 7.1.2 Bubble Oxygenator and Membrane Oxygenator: North America Cardiopulmonary Oxygenator Market – Revenue and Forecast, 2020-2028 (US$ Million)
8. North America Cardiopulmonary Oxygenator Market Analysis – by Application
8.1 Cardiac and Respiratory
- 8.1.1 Overview
- 8.1.2 Cardiac and Respiratory: North America Cardiopulmonary Oxygenator Market – Revenue and Forecast, 2020-2028 (US$ Million)
9. North America Cardiopulmonary Oxygenator Market Analysis – by Type
9.1 Disposable Cardiopulmonary Oxygenator and Reusable Cardiopulmonary Oxygenator
- 9.1.1 Overview
- 9.1.2 Disposable Cardiopulmonary Oxygenator and Reusable Cardiopulmonary Oxygenator: North America Cardiopulmonary Oxygenator Market – Revenue and Forecast, 2020-2028 (US$ Million)
10. North America Cardiopulmonary Oxygenator Market Analysis – by Age Group
10.1 Adults
- 10.1.1 Overview
- 10.1.2 Adults: North America Cardiopulmonary Oxygenator Market – Revenue and Forecast, 2020-2028 (US$ Million)
10.2 Pediatric
- 10.2.1 Overview
- 10.2.2 Pediatric: North America Cardiopulmonary Oxygenator Market – Revenue and Forecast, 2020-2028 (US$ Million)
10.3 Neonates
- 10.3.1 Overview
- 10.3.2 Neonates: North America Cardiopulmonary Oxygenator Market – Revenue and Forecast, 2020-2028 (US$ Million)
11. North America Cardiopulmonary Oxygenator Market – North America Analysis
11.1 Overview
11.2 North America
- 11.2.1 North America Cardiopulmonary Oxygenator Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 11.2.1.1 North America Cardiopulmonary Oxygenator Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 US:
North America Cardiopulmonary Oxygenator Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.1.1 US: North America Cardiopulmonary Oxygenator Market Breakdown, by Product
- 11.2.1.1.2 US: North America Cardiopulmonary Oxygenator Market Breakdown, by Application
- 11.2.1.1.3 US: North America Cardiopulmonary Oxygenator Market Breakdown, by Type
- 11.2.1.1.4 US: North America Cardiopulmonary Oxygenator Market Breakdown, by Age Group
- 11.2.1.2 Canada:
North America Cardiopulmonary Oxygenator Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.2.1 Canada: North America Cardiopulmonary Oxygenator Market Breakdown, by Product
- 11.2.1.2.2 Canada: North America Cardiopulmonary Oxygenator Market Breakdown, by Application
- 11.2.1.2.3 Canada: North America Cardiopulmonary Oxygenator Market Breakdown, by Type
- 11.2.1.2.4 Canada: North America Cardiopulmonary Oxygenator Market Breakdown, by Age Group
- 11.2.1.3 Mexico :
North America Cardiopulmonary Oxygenator Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.3.1 Mexico : North America Cardiopulmonary Oxygenator Market Breakdown, by Product
- 11.2.1.3.2 Mexico : North America Cardiopulmonary Oxygenator Market Breakdown, by Application
- 11.2.1.3.3 Mexico : North America Cardiopulmonary Oxygenator Market Breakdown, by Type
- 11.2.1.3.4 Mexico : North America Cardiopulmonary Oxygenator Market Breakdown, by Age Group
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Getinge AB
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 LivaNova Plc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Medtronic Plc
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Terumo Corp
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Nipro Medical Corp
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Microport Scientific Corp
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Braile Biomedica Industry, Commerce and Representation Ltd
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Chalice Medical Ltd
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Fresenius Medical Care AG & Co KGaA
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations